accines are critical to tackling the COVID-19 pandemic. We are bringing a vaccine to the public on a not-for-profit basis for emergency pandemic use.
Our vaccine development technology, scientific expertise and global manufacturing capabilities provide a foundation to develop a vaccine candidate and upscale production so that we can get it in the hands of those who need it most, as quickly and as safely as possible.
The availability of an Emergency Use Authorized single-dose COVID-19 vaccine could potentially protect hundreds of millions of people from serious and fatal outcomes of the disease. It also offers the hope of helping ease the burden placed on healthcare systems and communities.